News from the fight to
#SaveIndependentPharmacy
New York Times The Middlemen series
The Powerful Companies Driving Local Drugstores Out of Business
The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .
Pa. pharmacists say they’re receiving less money for drugs dispensed to Medicaid patients
Pennsylvania DHS says it will try to compel the insurance companies to reverse course, even though violated state contracts requiring that changes to pharmacy reimbursement rates be cleared with DHS first.
Walgreens Says It Will Close 1,200 Stores
The pharmacy giant said it would close the stores over the next three years and plans to “redeploy” the majority of the workers at the closed stores.
How Chaos at Chain Pharmacies Is Putting Patients at Risk
Pharmacists across the U.S. warn that the push to do more with less has made medication errors more likely. “I am a danger to the public,” one wrote to a regulator.
Note: This article was last updated on October 13, 2021.
Indiana paid $7 billion to administer prescription drug benefits in five-year period according to new report
Indiana lawmakers are calling for more oversight of “pharmacy benefit managers,” or “PBMs” for short, following a report presented to the Health Care Cost Oversight Task Force this week. According to that preliminary report, Indiana paid $7 billion to administer prescription drug benefits for Hoosiers enrolled in the state’s Medicaid program and state employee plan through FY 2017 through FY 2022.
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
Legalized Racketeering? How PBMs Skirt the Law to Rake in Billions
Pharmacy Benefit Managers (PBMs) have been under scrutiny lately for their actions as middlemen in the flow of prescription drugs from manufacturers to patients. But perhaps their worst actions are buried within a maze of consolidation and paperwork. Big Insurance has consolidated the entire pharmaceutical benefit, claim, and dispensing sector to squeeze as much money out of patients as possible.
Senator Wiener Responds to Governor’s Veto of Pharmacy Benefit Manager Bill
California Gov. Gavin Newsom vetoed legislation to rein in anticompetitive practices pharmacy benefit managers (PBMs) are using to drive up prescription drug prices and forcing independent pharmacies out of business. As a result, California remains one of the only states to leave the industry, which controls virtually all prescription drugs on the market, essentially unregulated. As a result, Californians will continue to pay more for health care and will continue to have limited access to their neighborhood pharmacies.
FTC head Lina Khan fighting Big Tech, Big Pharma and Big Groceries as trustbuster
FTC Chair Lena Khan was featured on a segment of 60 Minutes this past Sunday. The youngest-ever chair of the Federal Trade Commission sat down with Lesley Stahl to discuss how corporate consolidation and anti-competitive business practices are driving up prices throughout the U.S. economy.
Bruised by Government Report, Cigna's Pharmacy Business Sues the Federal Trade Commission
Whistleblower, former Cigna VP, and reformed insurance propagandist Wendell Potter takes you behind the scenes to provide a glimpse into the reasoning behind the lawsuit his former company filed this week against the Federal Trade Commission (FTC).
Cub in Brooklyn Park to close in November
Another Twin Cities pharmacy closes. The supermarket in the Starlite Center at 7555 W. Broadway is anticipated to shut down for good on November 16, according to a spokesperson for UNFI Retail, Cub’s parent company.
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Caremark, Express Scripts, Optum, and their affiliates created a broken rebate system that inflated insulin drug prices, boosting PBM profits at the expense of vulnerable patients, the FTC alleges.
Press Conference on PBM Abuse & H.R.9096 The Pharmacists Fight Back Act
Representatives Jake Auchincloss (D - MA) and Diana Harshbarger (R - TN) hold a press conference on PBM abuses, the destruction it causes to patients and pharmacies, and how The Pharmacists Fight Back Act H.R.9096 will stop it!
Rally outside Optum HQ brings debate over pharmacy benefits managers to Twin Cities
Patients, providers, and legislators gathered to allege biggest players are ballooning drug costs while running independent pharmacies out of business; Optum denied claims.
Medicare patient wrongly sent to collections in dispute between two UnitedHealth Group entities
The Minnesota-based insurer said he owed $275. The surgery center in St. Cloud wanted another $3,300. UnitedHealth owns both and is now apologizing.
Senator Wiener’s Landmark Prescription Drug Prices Bill Heads to the Governor
The landmark piece of legislation would have enacted the nation’s strongest regulations to rein in exploitative behavior by pharmacy benefit managers, also known as PBM abuse. The bill passed with bipartisan support in the state legislature only to be vetoed by California Governor Gavin Newsom.
These middlemen say they keep drug prices low. California lawmakers don’t buy it
Pharmacy benefit managers attempt to negotiate cost savings for insurers. California is considering new rules that would require them to pass their discounts on to consumers.
Chairman Comer Calls on PBM Executives to Correct Hearing Testimony
At the House Oversight Committee’s hearing, the PBM chief executives made statements that contradict the Committee’s and the Federal Trade Commission’s findings about the PBMs’ self-benefitting practices that jeopardize patient care, undermine local pharmacies, and raise prescription drug prices. The chief executives for CVS Caremark, Express Scripts, and Optum Rx claimed they do not steer patients to PBM-owned pharmacies. The executives also made claims contradicting the Committee’s and FTC’s findings regarding contract negotiations, contract opt outs, and payments to pharmacies.
Podcast: PBM Problems (Part 3): Monopoly Power in Prescription Drug Markets with Luke Slindee, PharmD
We all know the cost of prescription drugs in the U.S. is a problem. How did we get here and what can we do about it?
From the podcast MTVA Unscripted: Empowering the Move to Value Based Healthcare
The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .